American International Group Inc downsized its position by shedding 23,585 shares a decrease of 27.3%. Recently, analysts have updated the overall rating to 2.2.
Investors are feeling more bullish lately if you evaluate the fall in short interest. Advisors Asset Management Inc. lifted its holdings in Eastman Chemical by 149.9% during the 2nd quarter. The Edgepoint Investment Group Inc holds 1.61M shares with $135.52 billion value, down from 1.95M last quarter. Laurion Capital Management LP lifted its holdings in Eastman Chemical by 689.5% in the second quarter. The basic materials company reported $2.19 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $2.03 by $0.16. PGGM Investments lifted its holdings in shares of Eastman Chemical by 259.5% during the 3rd quarter.
Shares of Eastman Chemical Company (NYSE:EMN) traded up 0.86% in the last session while performance was up 90.75% in the last five days. Kentucky Retirement Sys Ins Trust Fund holds 0.06% of its portfolio in Eastman Chemical Company (NYSE:EMN) for 3,994 shares. Prudential Financial Inc. now owns 561,295 shares of the basic materials company's stock worth $47,143,000 after acquiring an additional 16,260 shares during the last quarter. Finally, DnB Asset Management AS grew its position in Eastman Chemical by 9.4% during the 2nd quarter. Institutional investors and hedge funds own 83.32% of the company's stock. Citigroup maintained Eastman Chemical Company (NYSE:EMN) rating on Wednesday, July 12. If you are accessing this news story on another domain, it was copied illegally and republished in violation of USA and global copyright & trademark legislation. National Bank Of The West reported 0.34% in Eastman Chemical Company (NYSE:EMN).
Several other equities analysts have also recently commented on EMN. October 30 investment analysts at Wells Fargo & Company maintained a stock rating of "Outperform" projecting a price of $102.00.
These firms have modified their investment in EMN. Finally, BidaskClub cut Eastman Chemical from a "buy" rating to a "hold" rating in a research note on Friday, July 28th.
On October 30 KeyCorp left the stock rating at "Buy" targeting a price of $108.00.
On October 30 Royal Bank Of Canada made no change to the company rating of "Sector Perform" targeting a price of $93.00. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and nine have issued a buy rating to the company. The stock presently has a consensus rating of "Hold" and an average target price of $96.00.
In related news, Director Renee J. Hornbaker sold 4,000 shares of the company's stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $84.43, for a total value of $337,720.00.
Currently, the stock carries a price to earnings ratio of 21.55, a price to book ratio of 3.53, and a price to sales ratio of 1.43. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Perry Stuckey sold 5,200 shares of the company's stock in a transaction on Tuesday, October 31st. The shares were sold at an average price of $92.12, for a total transaction of $479,024.00. The disclosure for this sale can be found here.
Since May 31, 2017, it had 0 insider purchases, and 1 insider sale for $319,520 activity.
Shares of Eastman Chemical Company (NYSE EMN) traded up $0.77 during midday trading on Monday, reaching $90.75. The latest exchange of 2.22 Million shares is below its average trading activity of 2.71 Million shares. The company now has a P/E ratio of 13.22 and market capitalization is 13.09B. The company has a debt-to-equity ratio of 1.24, a quick ratio of 0.94 and a current ratio of 1.83. Eastman Chemical Company has a 1 year low of $73.52 and a 1 year high of $94.96.
Eastman Chemical (NYSE:EMN) last announced its earnings results on Thursday, October 26th. EPS ratio determined by looking at last 12 month figures is 6.89. Eastman Chemical had a net margin of 10.89% and a return on equity of 22.77%. The business had revenue of $2.47 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same quarter in the previous year, the business earned $1.86 EPS.
Walter Keenan Fincl Consulting Mi Adv has invested 0.17% in Eastman Chemical Company (NYSE:EMN). The Company's segments include Additives & Functional Products (AFP), Advanced Materials (AM), Chemical Intermediates (CI), and Fibers.